HomeTMPV › Filing
🔔 Get instant alerts when TMPV files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 14 May 2026, 16:49 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q4FY26 - Consolidated revenue ₹105.4K Cr (+7.2% Q4FY25), EBITDA margin 13.1%, PAT strong - Tata Passenger Vehicles: Q4 revenue ₹18.7K Cr (+49.4% y-y), EBITDA margin 9.4%, PBT ₹1.1K Cr - JLR Q4 revenue £6.9bn (-11.1% y-y), adjusted EBIT margin 9.2%, volumes recovering post-cyber incident - FY27 outlook: focus on growth, cost savings of £1.7bn, breakeven volume target 300k units in 2 years - New product launches, capacity expansion, and EV adoption prioritized for profitable growth
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 TMPV — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add TMPV to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Tata Motors Passenger Vehicles Ltd

Important. The summary above is generated automatically from Tata Motors Passenger Vehicles Ltd's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.